0001209191-21-026064.txt : 20210408
0001209191-21-026064.hdr.sgml : 20210408
20210408161331
ACCESSION NUMBER: 0001209191-21-026064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210407
FILED AS OF DATE: 20210408
DATE AS OF CHANGE: 20210408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alland Leila
CENTRAL INDEX KEY: 0001825216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39539
FILM NUMBER: 21815064
MAIL ADDRESS:
STREET 1: C/O PMV PHARMACEUTICALS, INC.
STREET 2: 8 CLARKE DRIVE, SUITE 3
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001699382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463218129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 642-6664
MAIL ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-07
0
0001699382
PMV Pharmaceuticals, Inc.
PMVP
0001825216
Alland Leila
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY
NJ
08512
0
1
0
0
Chief Medical Officer
Common Stock
2021-04-07
4
M
0
4000
3.90
A
4000
D
Common Stock
2021-04-07
4
S
0
3972
33.8572
D
28
D
Common Stock
2021-04-07
4
S
0
28
34.4211
D
0
D
Employee Stock Option (right to buy)
3.90
2021-04-07
4
M
0
4000
0.00
D
2030-02-04
Common Stock
4000
373850
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.37 to $34.50, inclusive.
One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.
/s/ Winston Kung, by power of attorney
2021-04-08